Ken Griffin Ingevity Corp Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$43.47 - $55.12 $295,596 - $374,816	-6,800 Reduced 52.31%	6,200 $271,000
Q1 2024 May 15, 2024	BUY	$40.04 - $48.95 $168,168 - $205,590	4,200 Added 47.73%	13,000 $620,000
Q4 2023 Feb 14, 2024	SELL	$37.42 - $47.96 $258,198 - $330,924	-6,900 Reduced 43.95%	8,800 $415,000
Q3 2023 Nov 14, 2023	BUY	$46.86 - $64.31 $267,102 - $366,567	5,700 Added 57.0%	15,700 $747,000
Q2 2023 Aug 14, 2023	SELL	$47.19 - $74.01 $217,074 - $340,446	-4,600 Reduced 31.51%	10,000 $581,000
Q1 2023 May 15, 2023	BUY	$68.71 - $90.75 $893,229 - $1.18 Million	13,000 Added 812.5%	14,600 $1.04 Million
Q4 2022 Feb 14, 2023	SELL	$61.2 - $78.95 $250,920 - $323,695	-4,100 Reduced 71.93%	1,600 $112,000
Q3 2022 Nov 14, 2022	SELL	$60.02 - $75.11 $60,020 - $75,110	-1,000 Reduced 14.93%	5,700 $346,000

282

34.8M

11.4K

2.8K

Ticker NGVT
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 38,048,800
Market Cap $1.57B
Description
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells har...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.